Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ornstein

Showing results (181-190 of 233) with videos related to

Pageof 24
Sort By:
FEBS Letters|January 9, 1995
Secondary structure in solution of two anti-HIV-1 hammerhead ribozymes as investigated by two-dimensional 1H 500 MHz NMR spectroscopy in waterR H Sarma, M H Sarma, R Rein, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2006
Antiallodynic and antihyperalgesic effects of selective competitive GLUK5 (GluR5) ionotropic glutamate receptor antagonists in the capsaicin and carrageenan models in ratsCarrie K Jones, Andrew Alt, Ann Marie Ogden, et al.
British Journal of Pharmacology|November 1, 1988
A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonistsD Lodge, S N Davies, M G Jones, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitutionP L Ornstein, M B Arnold, N K Allen, et al.
British Journal of Pharmacology|September 19, 2000
A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slicesA J Doherty, M J Palmer, Z A Bortolotto, et al.
Journal of Medicinal Chemistry|July 21, 2001
[3H]N-2-(4-(N-benzamido)phenyl)propyl-2-propanesulfonamide: a novel AMPA receptor potentiator and radioligandH Zarrinmayeh, D Bleakman, M R Gates, et al.
Bone Marrow Transplantation|April 3, 2001
Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescueP J Shaughnessy, D W Ririe, D L Ornstein, et al.
Neuropharmacology|September 1, 1995
In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acidD D Schoepp, D Lodge, D Bleakman, et al.
Neuropharmacology|July 29, 1998
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsA E Kingston, P L Ornstein, R A Wright, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activityP L Ornstein, M B Arnold, N K Allen, et al.
Pageof 24

Showing results (181-190 of 233) with videos related to

Sort By:
Pageof 24
FEBS Letters|January 9, 1995
Secondary structure in solution of two anti-HIV-1 hammerhead ribozymes as investigated by two-dimensional 1H 500 MHz NMR spectroscopy in waterR H Sarma, M H Sarma, R Rein, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2006
Antiallodynic and antihyperalgesic effects of selective competitive GLUK5 (GluR5) ionotropic glutamate receptor antagonists in the capsaicin and carrageenan models in ratsCarrie K Jones, Andrew Alt, Ann Marie Ogden, et al.
British Journal of Pharmacology|November 1, 1988
A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonistsD Lodge, S N Davies, M G Jones, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitutionP L Ornstein, M B Arnold, N K Allen, et al.
British Journal of Pharmacology|September 19, 2000
A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slicesA J Doherty, M J Palmer, Z A Bortolotto, et al.
Journal of Medicinal Chemistry|July 21, 2001
[3H]N-2-(4-(N-benzamido)phenyl)propyl-2-propanesulfonamide: a novel AMPA receptor potentiator and radioligandH Zarrinmayeh, D Bleakman, M R Gates, et al.
Bone Marrow Transplantation|April 3, 2001
Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescueP J Shaughnessy, D W Ririe, D L Ornstein, et al.
Neuropharmacology|September 1, 1995
In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acidD D Schoepp, D Lodge, D Bleakman, et al.
Neuropharmacology|July 29, 1998
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsA E Kingston, P L Ornstein, R A Wright, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activityP L Ornstein, M B Arnold, N K Allen, et al.
Pageof 24